Aggregated China Business Blogs



China Aoxing Receives Manufacturing Exclusivity for Cancer Pain Drug

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
November 28, 2007|


China Aoxing Pharmaceutical Company (CAXG.OB) received “designated manufacturer status” for Tilidine, an opioid pain medication, from the China State Food & Drug Administration. The designation means China Aoxing will have five years of manufacturing exclusivity for Tilidine.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • Abraxis Receives China Approval for Cancer Drug
  • Aoxing Pharmaceutical's Anti-Opioid Addiction Drug Approved by China’s FDA
  • China Aoxing Granted License for Addiction Drug, Still Lacks Firm Financial Footing
  • Benda's Jiangling Plant Receives Production Approval
  • Simcere Buys Cancer Drug Company

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |